GU Podcast (2020): Immune Checkpoint Inhibitors In RCC
AUAUniversity28 Loka 2020

GU Podcast (2020): Immune Checkpoint Inhibitors In RCC

Immune Checkpoint Inhibitors in RCC At the conclusion of this activity, participants will be able to: 1. Discuss the current immunotherapy options available for the treatment of RCC. 2. Describe both completed and accruing clinical trials that are defining the paradigms of immunotherapy use in RCC. 3. Identify and manage immune related adverse events. This educational series is supported by independent educational grants from: Astellas AstraZeneca Bristol Myers Squibb Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Merck Pfizer, Inc Sanofi Genzyme UroGen Pharma, Inc. CME Available: https://auau.auanet.org/node/29846

Jaksot(421)

AUA SIU Symposium Therapeutic Advances In Immuno - Oncology

AUA SIU Symposium Therapeutic Advances In Immuno - Oncology

The American Urological Association (AUA) and Società Italiana di Urologia (SIU) have collaborated to develop an independent educational activity to review the latest updates in immuno-oncology. This...

5 Marras 201950min

Immune Checkpoint Inhibitors In Renal Cell Carcinoma

Immune Checkpoint Inhibitors In Renal Cell Carcinoma

Co-Host: William Huang, MD At the conclusion of these activities, participants will be able to: 1. Discuss the current immunotherapy options available for the treatment of RCC. 2. Describe both compl...

31 Loka 201935min

AUA2019 Take Home Messages - Female Urology And Incontinence - Reconstruction

AUA2019 Take Home Messages - Female Urology And Incontinence - Reconstruction

Take Home Messages: Female Urology/Incontinence Ariana Smith, MD University of Pennsylvania Take Home Messages: Reconstruction Giulia Lane, MD Urology Fellow, FPMRS University of Michigan

25 Loka 201916min

Sequencing Of Agents And Combination Therapy In Castrate Resistant Prostate Cancer

Sequencing Of Agents And Combination Therapy In Castrate Resistant Prostate Cancer

Co-Host: Maxwell Meng, MD At the conclusion of these activities, participants will be able to: 1. Identify treatments for non-metastatic and metastatic CRPC and describe the proper order for their ad...

17 Loka 201938min

The Role of Immune Checkpoint Inhibitors in Bladder Cancer

The Role of Immune Checkpoint Inhibitors in Bladder Cancer

Co-Host: Robert Svatek, MD At the conclusion of these activities, participants will be able to: 1. Recognize both historic and newer immunotherapy options in the treatment of bladder cancer. 2. Descr...

10 Loka 201931min

Treatment For Metastatic Hormone Sensitive Prostate Cancer (M - HSPC)

Treatment For Metastatic Hormone Sensitive Prostate Cancer (M - HSPC)

Co-Host: Kelvin Moses, MD At the conclusion of these activities, participants will be able to: 1. Identify the active agents and their mechanism of action in the management of metastatic HSPC. 2. Des...

3 Loka 201923min

Update Series v38l1 Diagnosis And Management Of Pheochromocytoma

Update Series v38l1 Diagnosis And Management Of Pheochromocytoma

Please enjoy this free lesson of the AUA Update Series Volume 38 Lesson 1: Diagnosis and Management of Pheochromocytoma Please send any comments to education@auanet.org

30 Syys 201924min

Clinical Investigations in the Treatment of Urothelial Carcinoma

Clinical Investigations in the Treatment of Urothelial Carcinoma

Co-Host: Yair Lotan, MD At the conclusion of these activities, participants will be able to: 1. Explain the scientific rationale for investigating immune oncology agents for BCG unresponsive disease...

25 Syys 201925min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
voi-hyvin-meditaatiot-2
psykopodiaa-podcast
rss-narsisti
adhd-podi
rss-liian-kuuma-peruna
rss-valo-minussa-2
aamukahvilla
jari-sarasvuo-podcast
rss-uskonto-on-tylsaa
rss-duodecim-lehti
rss-luonnollinen-synnytys-podcast
rss-arkea-ja-aurinkoa-podcast-espanjasta
rss-niinku-asia-on
kesken
salainen-paivakirja
psykologia
ihminen-tavattavissa-tommy-hellsten-instituutti
leveli
rss-tietoinen-yhteys-podcast-2